子宫腺肌症对胎盘相关产科并发症的影响
这项为期12年(2010-2022)的回顾性队列研究纳入59例子宫腺肌症患者和62例对照,共203次分娩。子宫腺肌症组不良胎盘功能结局发生率为27%,对照组为11%(P=0.005);校正母亲年龄、产次和阿司匹林使用后,子宫腺肌症组妊娠期高血压疾病风险(校正OR 5.91,95%CI 1.50-30.0;P=0.017)和不良胎盘功能结局风险(校正OR 3.44,95%CI 1.53-8.09;P=0.003)均升高。
要点
- 子宫腺肌症组不良胎盘功能结局发生率为27%,对照组为11%(P=0.005)。
- 校正后子宫腺肌症组妊娠期高血压疾病风险升高(校正OR 5.91,95%CI 1.50-30.0;P=0.017)。
- 校正后子宫腺肌症组不良胎盘功能结局风险升高(校正OR 3.44,95%CI 1.53-8.09;P=0.003)。
核心结论
- 子宫腺肌症与不良胎盘功能结局及妊娠期高血压疾病风险升高显著相关。
- 这些发现提示子宫腺肌症可能对妊娠有独特影响,作者指出需要进一步研究以阐明子宫腺肌症的具体超声特征及其对胎盘功能的影响。
研究设计与样本
- 12年回顾性队列研究(2010-2022),通过超声评估有子宫腺肌症相关症状的患者。
- 纳入59例子宫腺肌症患者和62例对照,共203次分娩(子宫腺肌症组90次,对照组113次)。
- 排除子宫内膜异位症、子宫肌瘤及子宫畸形患者,以及使用辅助生殖技术者。
主要发现
- 两组人口学特征无临床显著差异。
- 子宫腺肌症组不良胎盘功能结局发生率为27%,对照组为11%(P=0.005)。
- 校正母亲年龄、产次和阿司匹林使用后,子宫腺肌症组妊娠期高血压疾病风险升高(校正OR 5.91,95%CI 1.50-30.0;P=0.017)。
- 校正母亲年龄、产次和阿司匹林使用后,子宫腺肌症组不良胎盘功能结局风险升高(校正OR 3.44,95%CI 1.53-8.09;P=0.003)。
关键数值与推荐
- 主要结局为胎盘相关不良结局的复合指标,包括早产、小于胎龄儿、妊娠期高血压疾病、胎盘早剥和产后出血。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要进一步研究以阐明子宫腺肌症的具体超声特征及其对胎盘功能的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the relationship between sonographic diagnosis of isolated adenomyosis and placenta-associated obstetric outcomes? DESIGN: In this 12-year retrospective cohort study (2010-2022), patients presenting with adenomyosis-related symptoms were assessed via ultrasound. The study included 59 women diagnosed with adenomyosis and 62 controls, leading to 203 births (90 in the adenomyosis group and 113 in the control group). Patients with endometriosis, uterine fibroids and anomalies, and those using assisted reproductive technology were excluded. The primary outcome focused on a composite of placenta-associated adverse outcomes, including preterm birth, small-for-gestational-age fetuses, hypertensive disorders of pregnancy, placental abruption and post-partum haemorrhage. RESULTS: No clinically significant differences in demographic characteristics were noted between the two groups. However, the adenomyosis group showed a significantly higher rate of adverse placental function outcomes (27%) compared with the control group (11%, P = 0.005). Adjusted analyses for maternal age, parity and aspirin usage revealed increased risk of hypertensive disorders (adjusted OR 5.91, 95% CI 1.50-30.0; P = 0.017) and adverse placental function outcomes (adjusted OR 3.44, 95% CI 1.53-8.09; P = 0.003) in the adenomyosis group. CONCLUSION: Adenomyosis is significantly associated with increased risk of adverse placental function outcomes and hypertensive disorders of pregnancy. These findings suggest that adenomyosis may have a distinct impact on pregnancy, underscoring the need for further research to elucidate specific sonographic characteristics of adenomyosis and their effects on placental function.
引用
- Matot R, Bar-Peled U, Geron Y, et al. Effect of adenomyosis on placenta-related obstetric complications. Reprod Biomed Online. 2024. PMID: 39504845. doi:10.1016/j.rbmo.2024.104414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。